NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
Study Number: 

NCG 275215 C1

Phase: 
2
Trial categories: 
Advanced Solid Tumor
Principal Investigator: